BioGaia ATB Probiotics Strawberry Flavor 10 Tablets

BioGaia® lactic acid bacteria are developed from the patented microbial strain Lactobacillus reuteri DSM 17938 and recommended by healthcare professionals around the world. In gocce or chewable tablets, each family member will find the suitable dosage. | A UNIQUE MICROBIOTIC STRAIN! Exclusive to Lactobacillus reuteri Protectis ® (DSM 17938) The bacterial strain Lactobacillus reuteri Protectis® was identified in 1962 and then isolated in 1990 from the breast milk of women living in the Peruvian highlands. The bacterial strain must be clearly identified. Different strains of the same species have different properties. Lactobacillus reuteri Protectis® (strain DSM 17938) belongs to the Lactobacillus reuteri species, but the demonstrated results of Lactobacillus reuteri Protectis® (DSM 17938), through more than 150 clinical studies, cannot under any circumstances be extrapolated to another strain and are exclusively applicable to products from the BioGaia® range.| DEVELOPED BY ONE OF THE WORLD LEADERS Presentation of the BIOGAIA AB Laboratory BIOGAIA AB is a biotechnology laboratory, specialized in the development and marketing of products designed based on Lactobacillus reuteri Protectis® (strain DSM 17938) and Lactobacillus reuteri Gastrus® (strain DSM 17938 + strain ATCC PTA 6475). | Founded in 1990, BIOGAIA AB is recognized as a global leader and has over 25 years of experience. BIOGAIA AB has developed over the years a network of independent researchers and experts around the world.| BioGaia® products are now distributed in more than 90 countries.| Did you know ? Today, more than 150 clinical studies and 13 meta-analyses published and performed on more than 14.500 patients, make Lactobacillus reuteri Protectis® one of the most documented strains in the world. Patented, it is the exclusive property of the BIOGAIA AB Laboratory.